Treatment of eye diseases and excessive neovascularization using a combined therapy

Details for Australian Patent Application No. 2009269149 (hide)

Owner Angioblast Systems, Inc.

Inventors Schuster, Michael David; Itescu, Silviu

Agent FB Rice

Pub. Number AU-A-2009269149

PCT Pub. Number WO2010/005527

Priority 61/133,607 30.06.08 US; 2008903349 30.06.08 AU

Filing date 29 June 2009

Wipo publication date 14 January 2010

International Classifications

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/005527 Priority application(s): WO2010/005527

12 April 2012 Alteration of Name

  The name of the applicant has been altered to Mesoblast, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009269157-Method of demand valve oxygen therapy for rapid abort of cluster headache

2009269147-Polymers of isoprene from renewable resources